If we can’t walk it away, what will we do? Some 5.4 million Americans have Alzheimer’s, and the numbers are expected to swell as the baby boom generation ages. Some very important drug trials are going on right now: people who are genetically guaranteed to develop the disease–but who do not yet have any symptoms–will be given a drug that could stop it.
When the commonly-used skin cancer drug Bexarotene was first tested on mice, it appeared to quickly reverse the pathological, cognitive and memory deficits caused by the onset of Alzheimer’s.
300 of the participants will come from ONE family: an extended clan of 5,000 people who live in Medellín, Colombia, and remote mountain villages outside that city. Family members with a specific genetic mutation begin showing cognitive impairment around age 45, and full dementia around age 51. Their memories fade and the disease quickly affects their ability to move, eat, speak and communicate.
In the May 16th edition of the New York Times, Pam Belluck quotes family member Gladys Betancur as saying, "Because of this study, we do not feel as alone. Sometimes we think that life is ending, but now we feel that people are trying to help us." Her mother died of Alzheimer’s, three of her siblings already have symptoms, and she had a hysterectomy so she wouldn’t pass the mutation on to her children.
This is a secret worth discovering–and here’s another one: A secret Indian tribe that nobody knew was there. We’ve already learned that Native Americans know some surprising things about the Visitors–now learn about the OTHER secrets they have too!